Dermatology Online Journal 2012-May
Purpuric drug eruption and alopecia induced by erlotinib.
يمكن للمستخدمين المسجلين فقط ترجمة المقالات
الدخول التسجيل فى الموقع
يتم حفظ الارتباط في الحافظة
الكلمات الدالة
نبذة مختصرة
We herein report a case of diffuse alopecia with pustules on the scalp and purpuric lesions on the lower legs in a Japanese man after treatment with erlotinib. This is a unique case in which rare skin eruptions simultaneously occurred. We discuss herein a combination of skin eruptions as an adverse reaction of epidermal growth factor-receptor (EGF-R) tyrosine kinase inhibitor. It is indispensable to be aware of rare skin reactions when applying molecular targeting therapies.